GSK3B and lung carcinoma: In lung cancer, DGCR5 bound to miR-1180 to suppress AKT, GSK-3β, and β-catenin expression, therefore suppressing the capacity of H520 and H1299 lung cancer cells to proliferate, migrate and invade [52].